Navigation Links
Boston Scientific Launches Third-Generation Platinum Chromium Drug-Eluting Stent
Date:5/19/2009

the inner surface of the stent. Integrating the Element Stent architecture and a platinum chromium alloy with an optimized drug release, the "Labcoat Element" Stent(2) is designed to deliver a powerful combination of procedural and clinical performance.

In the United States, the TAXUS Element Stent and PROMUS Element Stent are investigational devices and are limited by applicable law to investigational use only and are not available for sale.

The PROMUS Stent is a private-labeled Xience V(R) Everolimus-Eluting Coronary Stent System manufactured by Abbott and distributed by Boston Scientific. Xience V is a trademark of the Abbott Laboratories group of companies.

Boston Scientific is a worldwide developer, manufacturer and marketer of medical devices whose products are used in a broad range of interventional medical specialties. For more information, please visit: www.bostonscientific.com.

(1) TAXUS(R) Element(TM) and PROMUS(R) Element(TM) Drug-Eluting Stent Systems are CE mark pending; Element(TM) Bare-Metal Stent is under development. Not available for sale in the EEA (European Economic Area), U.S. and Japan.

(2) "Labcoat Element" drug-eluting stent system is under development. Not available for sale in the EEA, US and Japan.

Cautionary Statement Regarding Forward-Looking Statements

This press release contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934. Forward-looking statements may be identified by words like "anticipate," "expect," "project," "believe," "plan," "estimate," "intend" and similar words. These forward-looking statements are based on our beliefs, assumptions and estimates using information available to us at the time and are not intended to be guarantees of future events or performance. These forward-looking statements in
'/>"/>

SOURCE Boston Scientific Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Boston Scientific Data Show Real-World Survival Rates for Implantable Cardiac Device Patients Exceed Rates From Clinical Trials
2. Journal of American College of Cardiology Article Reports Fewer Repeat Procedures With Boston Scientifics TAXUS(R) Liberte(R) Stent
3. Boston Scientific Welcomes Publication of HORIZONS AMI Trial Results in New England Journal of Medicine
4. Clinical Data Reinforce Safety and Efficacy of Boston Scientifics Two Drug- Eluting Stent Platforms
5. New England Journal of Medicine Publishes Results from Boston Scientifics Landmark SYNTAX(TM) Trial
6. Boston Scientific Submits Final Modules to FDA for Approval of Second-Generation Small Vessel and Long Lesion Stents
7. Boston Scientific Begins Clinical Trial Enrollment for New Everolimus-Eluting Stent
8. Taxus Atlas Studies Reinforce Safety and Efficacy of Boston Scientifics Next-Generation Taxus Liberte Stent
9. Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008
10. Boston Scientific Completes Clinical Trial Enrollment for Third-Generation Drug-Eluting Stent
11. Wound Management Technologies, Inc. Announces Conference Plans in Boston and Additional Clinical Research on CellerateRx(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2015)... 2015 La sofisticada aplicación ... sistemas de imagen por Ultrasonidos   ofrece resultados más ... rápidos y un flujo de trabajo   optimizado, lo ... proceso de detección de Cardiopatías   ... el lanzamiento europeo de HeartModel A.I ...
(Date:8/28/2015)... , Aug. 28, 2015  Delays in the ... can slow down the decision-making process, resulting in ... absolutely critical for biopharmaceutical companies to develop a ... process for quicker and more meaningful insights. ... Practices, LLC, nearly three-quarters of benchmarked study participants ...
(Date:8/28/2015)... 28, 2015 According to a ... (Breast, Lung, Prostate) Type (Protein & Genetic Biomarkers) Profiling ... Prognostic) & Geography - Global Forecast to 2020", published ... reach around 17,689.0 Million USD by 2020 at a ... to 2020. Browse 191 Tables and ...
Breaking Medicine Technology:Philips presenta HeartModel A.I en el Congreso ESC 2015 2Philips presenta HeartModel A.I en el Congreso ESC 2015 3Philips presenta HeartModel A.I en el Congreso ESC 2015 4Philips presenta HeartModel A.I en el Congreso ESC 2015 5Expediting the Pharmaceutical Market Research Process for Faster Insights 2Cancer Biomarkers Market Worth 17,689.0 Million USD by 2020 2Cancer Biomarkers Market Worth 17,689.0 Million USD by 2020 3Cancer Biomarkers Market Worth 17,689.0 Million USD by 2020 4Cancer Biomarkers Market Worth 17,689.0 Million USD by 2020 5
... , , STAMFORD, Conn., Jan. 8 ... (Nasdaq: SPDE ), today announced that Health Canada, ... the Zargis Cardioscan(TM) device for sale in Canada. , ... a Bluetooth®-enabled electronic stethoscope and is designed to help ...
... 8 Somanetics Corporation (Nasdaq: SMTS ) will release its ... 30, 2009 before the opening of the market on Thursday, January ... Company will host a conference call that will be webcast live ... On the conference call, Bruce Barrett, Somanetics, president and chief executive ...
Cached Medicine Technology:Zargis Cardioscan Cleared for Sale in Canada 2Zargis Cardioscan Cleared for Sale in Canada 3Somanetics Corporation to Release Fourth Quarter and Fiscal 2009 Financial Results and Host Conference Call January 21, 2010 2
(Date:8/31/2015)... ... August 31, 2015 , ... For 12 years, since ... acknowledged September 26th as Mesothelioma Awareness Day . On this day, and in ... several ways of becoming involved and helping the cause. , “One of the ways ...
(Date:8/31/2015)... ... August 31, 2015 , ... Westchester Insurance, ... Prairie, is teaming up with the Tarrant County chapter of Meals on Wheels ... Wheels is the oldest and largest national organization that supports the more than ...
(Date:8/31/2015)... ... 2015 , ... The Workgroup for Electronic Data Interchange ... to create efficiencies in healthcare information exchange, announces the agenda and open registration ... Hyatt Regency Reston in Reston, Va. from October 26-29, WEDI-Con will convene hundreds ...
(Date:8/31/2015)... (PRWEB) , ... August 31, 2015 , ... Juvent Sports ... growing list of major sports figures who are finding joint pain relief after using ... former #1 men’s tennis player in the world said, “For the first time in ...
(Date:8/31/2015)... ... 2015 , ... PartnerTech hosted prospective businesses in ... a tour of their North American facility following the S.M.A.R.T Community Summit. PartnerTech ... business in the U.S. , The PartnerTech Inc. North American facility in ...
Breaking Medicine News(10 mins):Health News:Cancer Research Organization Paints the World in Mesothelioma Awareness 2Health News:Cancer Research Organization Paints the World in Mesothelioma Awareness 3Health News:Westchester Insurance and the Meals on Wheels Association Announce Joint Charity Effort to Provide Nutritious Meals for Senior Citizens 2Health News:Westchester Insurance and the Meals on Wheels Association Announce Joint Charity Effort to Provide Nutritious Meals for Senior Citizens 3Health News:WEDI Announces Program for Annual Fall Conference: WEDI-Con 2015 2Health News:WEDI Announces Program for Annual Fall Conference: WEDI-Con 2015 3Health News:Mats Wilander, 7 Grand Slam Title Winner and Tennis Legend, Now Plays Without Joint Pain 2Health News:Mats Wilander, 7 Grand Slam Title Winner and Tennis Legend, Now Plays Without Joint Pain 3Health News:PartnerTech Supports Economic Growth as Host 2
... David Brennan was elected board chairman of the Pharmaceutical Research ... meeting.In a speech to the meeting attendees, Brennan called on ... system to work together in a new collaborative and bipartisan ... , Increased ...
... Benefit the IP - Over $2,200 In Donations ... Verger, award-winning photographer and philanthropist is taking his ... to help raise awareness for the nonprofit Innocence ... grateful to Mr. Verger for using his considerable ...
... DEBRECEN, Hungary, April 3 Bertalan Mesko, medical blogger and ... that he presented in Nijmegen, The Netherlands at a Health ... shape the future of medicine. E-patients are patients who communicate ... information online and sometimes they are more up-to-date than their ...
... Holdings, Inc. (NYSE: ZMH ; SWX: ZMH) announced ... will be broadcast live over the Internet on Thursday, April ... release detailing the quarterly results will be made available at ... webcast can be accessed via Zimmer,s Investor Relations website at ...
... stems from discovery of mutation affecting infertility, , , THURSDAY, ... infertility in men could point the way to a ... , "We have identified CATSPER1 as a gene that ... finding which could lead to future infertility therapies that ...
... of neurodegenerative disease , , FRIDAY, April 3 (HealthDay News) ... to prevent brain cells from falling victim to the ... in the preliminary stages, and the researchers don,t know ... Huntington,s disease expert said the findings could lead to ...
Cached Medicine News:Health News:AstraZeneca's David Brennan Elected PhRMA Board Chairman 2Health News:AstraZeneca's David Brennan Elected PhRMA Board Chairman 3Health News:AstraZeneca's David Brennan Elected PhRMA Board Chairman 4Health News:Acclaimed New England Photographer Donald Verger Holds 'Faces of Innocence' Charity Event for the Innocence Project 2Health News:Genetic Finding May Lead to Male Contraceptive 2Health News:Scientists Uncover New Weapon Against Huntington's 2
... 1991 Intersurgical Incorporated manufactures ... heat and moisture exchangers, ... products, hand-held nebulizers and ... accessories and connectors for ...
... product line has the right product for ... and from intubated patients to patients with ... both anesthesia and critical care applications., ... protection for patients and staff members. This ...
Bacterial/Viral Filters for Anesthesia and Respiratory Applications...
Bacterial/Viral Filters for Anesthesia and Respiratory Applications...
Medicine Products: